Edgewise Therapeutics Inc...

NASDAQ: EWTX · Real-Time Price · USD
14.15
0.22 (1.58%)
At close: Aug 15, 2025, 3:59 PM
14.31
1.10%
After-hours: Aug 15, 2025, 05:00 PM EDT

Edgewise Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-133.81M -100.16M -67.64M -42.81M
Depreciation & Amortization
2.29M 1.73M 538K 272K
Stock-Based Compensation
24.71M 17.56M 10.92M 4.4M
Other Working Capital
8.59M -1.47M 4.04M 1.98M
Other Non-Cash Items
-12.54M -9.52M -543K 2.29M
Deferred Income Tax
n/a n/a n/a -2.29M
Change in Working Capital
10.33M -1.56M 4.09M 4.63M
Operating Cash Flow
-109.03M -91.95M -52.63M -33.51M
Capital Expenditures
-1.31M -5.75M -5.55M -668K
Cash Acquisitions
n/a n/a 65.03K 241.56K
Purchase of Investments
-477.06M -255.87M -292.39M -288.2M
Sales Maturities Of Investments
293.71M 364.5M 227.36M 46.64M
Other Investing Acitivies
n/a n/a -65.03K -241.56K
Investing Cash Flow
-184.66M 102.89M -70.58M -242.23M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
10.11M -165K 474K 236K
Financial Cash Flow
249.25M 53.17M 129.64M 186.38M
Net Cash Flow
-44.43M 64.1M 6.43M -89.35M
Free Cash Flow
-110.34M -97.69M -58.18M -34.17M